» Articles » PMID: 29671393

Predicting and Understanding Comprehensive Drug-drug Interactions Via Semi-nonnegative Matrix Factorization

Overview
Journal BMC Syst Biol
Publisher Biomed Central
Specialty Biology
Date 2018 Apr 20
PMID 29671393
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Drug-drug interactions (DDIs) always cause unexpected and even adverse drug reactions. It is important to identify DDIs before drugs are used in the market. However, preclinical identification of DDIs requires much money and time. Computational approaches have exhibited their abilities to predict potential DDIs on a large scale by utilizing pre-market drug properties (e.g. chemical structure). Nevertheless, none of them can predict two comprehensive types of DDIs, including enhancive and degressive DDIs, which increases and decreases the behaviors of the interacting drugs respectively. There is a lack of systematic analysis on the structural relationship among known DDIs. Revealing such a relationship is very important, because it is able to help understand how DDIs occur. Both the prediction of comprehensive DDIs and the discovery of structural relationship among them play an important guidance when making a co-prescription.

Results: In this work, treating a set of comprehensive DDIs as a signed network, we design a novel model (DDINMF) for the prediction of enhancive and degressive DDIs based on semi-nonnegative matrix factorization. Inspiringly, DDINMF achieves the conventional DDI prediction (AUROC = 0.872 and AUPR = 0.605) and the comprehensive DDI prediction (AUROC = 0.796 and AUPR = 0.579). Compared with two state-of-the-art approaches, DDINMF shows it superiority. Finally, representing DDIs as a binary network and a signed network respectively, an analysis based on NMF reveals crucial knowledge hidden among DDIs.

Conclusions: Our approach is able to predict not only conventional binary DDIs but also comprehensive DDIs. More importantly, it reveals several key points about the DDI network: (1) both binary and signed networks show fairly clear clusters, in which both drug degree and the difference between positive degree and negative degree show significant distribution; (2) the drugs having large degrees tend to have a larger difference between positive degree and negative degree; (3) though the binary DDI network contains no information about enhancive and degressive DDIs at all, it implies some of their relationship in the comprehensive DDI matrix; (4) the occurrence of signs indicating enhancive and degressive DDIs is not random because the comprehensive DDI network is equipped with a structural balance.

Citing Articles

HDN-DDI: a novel framework for predicting drug-drug interactions using hierarchical molecular graphs and enhanced dual-view representation learning.

Sun J, Zheng H BMC Bioinformatics. 2025; 26(1):28.

PMID: 39863877 PMC: 11765940. DOI: 10.1186/s12859-025-06052-0.


Accurate prediction of drug combination risk levels based on relational graph convolutional network and multi-head attention.

He S, Yun L, Yi H J Transl Med. 2024; 22(1):572.

PMID: 38880914 PMC: 11180398. DOI: 10.1186/s12967-024-05372-8.


Drug-drug interactions prediction based on deep learning and knowledge graph: A review.

Luo H, Yin W, Wang J, Zhang G, Liang W, Luo J iScience. 2024; 27(3):109148.

PMID: 38405609 PMC: 10884936. DOI: 10.1016/j.isci.2024.109148.


Multimodal CNN-DDI: using multimodal CNN for drug to drug interaction associated events.

Asfand-E-Yar M, Hashir Q, Shah A, Malik H, Alourani A, Khalil W Sci Rep. 2024; 14(1):4076.

PMID: 38374325 PMC: 10876630. DOI: 10.1038/s41598-024-54409-x.


KGE-UNIT: toward the unification of molecular interactions prediction based on knowledge graph and multi-task learning on drug discovery.

Zhang C, Zang T, Zhao T Brief Bioinform. 2024; 25(2).

PMID: 38348746 PMC: 10939374. DOI: 10.1093/bib/bbae043.


References
1.
Tatonetti N, Ye P, Daneshjou R, Altman R . Data-driven prediction of drug effects and interactions. Sci Transl Med. 2012; 4(125):125ra31. PMC: 3382018. DOI: 10.1126/scitranslmed.3003377. View

2.
Pahikkala T, Airola A, Pietila S, Shakyawar S, Szwajda A, Tang J . Toward more realistic drug-target interaction predictions. Brief Bioinform. 2014; 16(2):325-37. PMC: 4364066. DOI: 10.1093/bib/bbu010. View

3.
Zhou D, Bui K, Sostek M, Al-Huniti N . Simulation and Prediction of the Drug-Drug Interaction Potential of Naloxegol by Physiologically Based Pharmacokinetic Modeling. CPT Pharmacometrics Syst Pharmacol. 2016; 5(5):250-7. PMC: 4879473. DOI: 10.1002/psp4.12070. View

4.
Veith H, Southall N, Huang R, James T, Fayne D, Artemenko N . Comprehensive characterization of cytochrome P450 isozyme selectivity across chemical libraries. Nat Biotechnol. 2009; 27(11):1050-5. PMC: 2783980. DOI: 10.1038/nbt.1581. View

5.
Ding C, Li T, Jordan M . Convex and semi-nonnegative matrix factorizations. IEEE Trans Pattern Anal Mach Intell. 2009; 32(1):45-55. DOI: 10.1109/TPAMI.2008.277. View